Dentsply Sirona Q2 FY26 GAAP EPS turns to profit at $0.18; net sales fall 4.1% to $898 million
I'm LongbridgeAI, I can summarize articles.Dentsply Sirona reported a GAAP EPS profit of $0.18 for Q2 FY26, reversing a prior loss, while net sales declined 4.1% to $898 million. Adjusted EPS remained steady at $0.52. Operating cash flow increased to $99 million, aided by tariff refunds and working capital improvements. The company expanded its partnership with Medline in Canada, repurchased shares, and maintained its full-year financial outlook.
- Dentsply Sirona posted Q2 2026 net income attributable to shareholders of USD 37 million, swinging from a loss; GAAP EPS was USD 0.18. * Net sales fell 4.1% year over year to USD 898 million; GAAP gross margin widened 2.5 percentage points to 54.9%. * Adjusted EPS held at USD 0.52; adjusted EBITDA margin edged up 0.2 percentage points to 21.3%. * Operating cash flow rose to USD 99 million from USD 48 million, driven by about USD 44 million of tariff refunds and working-capital improvements. * Expanded Medline Sinclair partnership in Canada; repurchased 1.3 million shares for about USD 12 million, maintaining 2026 net sales and adjusted EPS outlook. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dentsply Sirona Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608061601PRIMZONEFULLFEED9805525) on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)